Mitigating Radiotoxicity in the Central Nervous System: Role of Proton Therapy
- 20 September 2023
- journal article
- review article
- Published by Springer Nature in Current Treatment Options in Oncology
- Vol. 24 (11) , 1524-1549
Abstract
Opinion statement Central nervous system (CNS) radiotoxicity remains a challenge in neuro-oncology. Dose distribution advantages of protons over photons have prompted increased use of brain-directed proton therapy. While well-recognized among pediatric populations, the benefit of proton therapy among adults with CNS malignancies remains controversial. We herein discuss the role of protons in mitigating late CNS radiotoxicities in adult patients. Despite limited clinical trials, evidence suggests toxicity profile advantages of protons over conventional radiotherapy, including retention of neurocognitive function and brain volume. Modelling studies predict superior dose conformality of protons versus state-of-the-art photon techniques reduces late radiogenic vasculopathies, endocrinopathies, and malignancies. Conversely, potentially higher brain tissue necrosis rates following proton therapy highlight a need to resolve uncertainties surrounding the impact of variable biological effectiveness of protons on dose distribution. Clinical trials comparing best photon and particle-based therapy are underway to establish whether protons substantially improve long-term treatment-related outcomes in adults with CNS malignancies.Keywords
Funding Information
- Berlin Institute of Health (BIH Charité Junior Clinician Scientist Program, BIH Charité Junior Clinician Scientist Program)
- NIH/NIC (NIH/NCI R38 Award (1R38CA245204))
- DFG (Germany´s Excellence Strategy – EXC-2049 – 390688087)
- Collaborative Research Center ReTune (TRR 295-424778381)
- BMBF
- DZNE
- DZHK
- eu
- Corona-Stiftung
- Fondation Leducq
- American Cancer Society
- American Academy of Neurology
- Amy Gallagher Foundation
- Derrick Wong Family Foundation
This publication has 183 references indexed in Scilit:
- Neural stem cell sparing by linac based intensity modulated stereotactic radiotherapy in intracranial tumorsRadiation Oncology, 2013
- Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategiesNeuro-Oncology, 2013
- Growth Hormone Secretion After Conformal Radiation Therapy in Pediatric Patients With Localized Brain TumorsJournal of Clinical Oncology, 2011
- Proton Stereotactic Radiosurgery for the Treatment of Benign MeningiomasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and TemozolomideClinical Cancer Research, 2011
- Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosisRadiation Oncology, 2011
- Risk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinomaPhysics in Medicine & Biology, 2010
- Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trialThe Lancet Oncology, 2009
- A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imagingJournal of the Neurological Sciences, 1993
- Tumors of the Brain and Nervous System after Radiotherapy in ChildhoodNew England Journal of Medicine, 1988